These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34309028)

  • 21. Blood donor deferral pattern in Iran.
    Birjandi F; Gharehbaghian A; Delavari A; Rezaie N; Maghsudlu M
    Arch Iran Med; 2013 Nov; 16(11):657-60. PubMed ID: 24206408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of short-term, temporary deferral on future blood donation.
    Halperin D; Baetens J; Newman B
    Transfusion; 1998 Feb; 38(2):181-3. PubMed ID: 9531951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of alternative minimum recall intervals between whole blood donations.
    Sadique Z; Willis S; Corte K; Pennington M; Moore C; Kaptoge S; Angelantonio ED; Miflin G; Roberts DJ; Grieve R
    PLoS One; 2022; 17(8):e0272854. PubMed ID: 35976959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An analysis of first-time blood donors return behaviour using regression models.
    Kheiri S; Alibeigi Z
    Transfus Med; 2015 Aug; 25(4):243-8. PubMed ID: 25764950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and causes of pre-donation deferrals among potential plateletpheresis donors at a blood center in Eastern China.
    Zhu H; Wang J; Lin H
    Transfus Clin Biol; 2023 May; 30(2):189-194. PubMed ID: 36257581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of a post-donation hemoglobin testing strategy on efficiency and safety of whole blood donation in England: A modeling study.
    Kim LG; Bolton T; Sweeting MJ; Bell S; Fahle S; McMahon A; Walker M; Ferguson E; Miflin G; Roberts DJ; Di Angelantonio E; Wood AM
    Transfusion; 2023 Mar; 63(3):541-551. PubMed ID: 36794597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a prediction model for low hemoglobin deferral in a large cohort of whole blood donors.
    Baart AM; de Kort WL; Atsma F; Moons KG; Vergouwe Y
    Transfusion; 2012 Dec; 52(12):2559-69. PubMed ID: 22519683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of the need for shared blood donor deferral registries.
    Domen RE; Grewal ID; Hirschler NV; Hoeltge GA
    Int J Qual Health Care; 1997 Feb; 9(1):35-41. PubMed ID: 9154489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-donation deferral of blood donors in a Brazilian blood bank: a 10-year experience.
    Dias PB; Lissa NM; Skare T; Fávero KB; Almeida PTR; Nisihara R
    Transfus Med; 2019 Dec; 29(6):448-453. PubMed ID: 31608541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seasonal temperature variation and the rate of donor deferral for low hematocrit in the American Red Cross.
    Sebok MA; Notari EP; Chambers LA; Benjamin RJ; Eder AF
    Transfusion; 2007 May; 47(5):890-4. PubMed ID: 17465955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recruitment and representativeness of blood donors in the INTERVAL randomised trial assessing varying inter-donation intervals.
    Moore C; Bolton T; Walker M; Kaptoge S; Allen D; Daynes M; Mehenny S; Sambrook J; Watkins NA; Miflin G; Di Angelantonio E; Ouwehand WH; Roberts DJ; Danesh J; Thompson SG
    Trials; 2016 Sep; 17(1):458. PubMed ID: 27645285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demographical Pattern of Blood Donors and Pre-Donation Deferral Causes in Dhahran, Saudi Arabia.
    Elsafi SH
    J Blood Med; 2020; 11():243-249. PubMed ID: 32765148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of predonation blood donor deferrals in a university hospital.
    Bashawri LA
    J Family Community Med; 2005 May; 12(2):79-84. PubMed ID: 23012080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Educating donors about deferrals through the provision of tailored materials: Findings from a survey of deferred donors.
    Gemelli CN; Kruse SP; Thijsen A; Van Dyke N; Davison TE
    Transfusion; 2021 Mar; 61(3):822-829. PubMed ID: 33615506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for complications in donors at first and repeat whole blood donation: a cohort study with assessment of the impact on donor return.
    Wiersum-Osselton JC; Marijt-van der Kreek T; Brand A; Veldhuizen I; van der Bom JG; de Kort W
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s28-36. PubMed ID: 23867173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies.
    Correll PK; Law MG; Seed CR; Gust A; Buring M; Dax EM; Keller AJ; Kaldor JM
    Vox Sang; 2001 Jul; 81(1):6-11. PubMed ID: 11520409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term serologic follow-up of blood donors with biologic false reactivity on an anti-human T-cell lymphotropic virus Types I and II chemiluminescent immunoassay and implications for donor management.
    Kiely P; Thomas B; Kebede M
    Transfusion; 2008 Sep; 48(9):1833-41. PubMed ID: 18503614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Removal of UK-donor deferral for variant Creutzfeldt-Jakob disease: A large donation gain in Australia.
    Hoad VC; Seed CR; Kiely P; Styles CE; McManus H; Law M; Kaldor J; Gosbell IB
    Vox Sang; 2023 Oct; 118(10):891-894. PubMed ID: 37563946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New tatt? We're ok with that! Relaxing the tattoo deferral for plasmapheresis donors maintains safety and increases donations.
    Styles CE; Hoad VC; Harley R; Kaldor J; Gosbell IB
    Vox Sang; 2024 Jun; ():. PubMed ID: 38925639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
    Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
    AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.